Immune Checkpoint Inhibitors in Kidney Transplant Recipients: A French Multicenter Retrospective Cohort Study.

Transplant Direct · 2025 · PMC12316348 · PMID 40755508

Europe PMC DOI

hedged sentence

0.3000

closest p · 6.0× alpha

0.3000

boldest claim

The sentences

a nonsignificant trendP = 0.3not close (p > 0.1)

There was a nonsignificant trend toward higher corticosteroid doses (7.8 ± 8.5 versus 5.0 ± 1.7 mg/d; P = 0.3) and a higher proportion of tacrolimus-treated patients at ICI initiation (46% versus 22%: P = 0.3) in the nonrejection group.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.